Literature DB >> 17088899

Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells.

Quan Bin Zhang1, Xiao Yan Ji, Qiang Huang, Jun Dong, Yu De Zhu, Qing Lan.   

Abstract

Understanding of the differentiation profile of brain tumor stem cells (BTSCs), the key ones among tumor cell population, through comparison with neural stem cells (NSCs) would lend insight into the origin of glioma and ultimately yield new approaches to fight this intractable disease. Here, we cultured and purified BTSCs from surgical glioma specimens and NSCs from human fetal brain tissue, and further analyzed their cellular biological behaviors, especially their differentiation property. As expected, NSCs differentiated into mature neural phenotypes. In the same differentiation condition, however, BTSCs exhibited distinguished differences. Morphologically, cells grew flattened and attached for the first week, but gradually aggregated and reformed floating tumor sphere thereafter. During the corresponding period, the expression rate of undifferentiated cell marker CD133 and nestin in BTSCs kept decreasing, but 1 week later, they regained ascending tendency. Interestingly, the differentiated cell markers GFAP and beta-tubulinIII showed an expression change inverse to that of undifferentiated cell markers. Taken together, BTSCs were revealed to possess a capacity to resist differentiation, which actually represents the malignant behaviors of glioma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088899     DOI: 10.1038/sj.cr.7310104

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  26 in total

1.  High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.

Authors:  Alessandro Raso; Samantha Mascelli; Roberto Biassoni; Paolo Nozza; Marcel Kool; Angela Pistorio; Elisabetta Ugolotti; Claudia Milanaccio; Sara Pignatelli; Manuela Ferraro; Marco Pavanello; Marcello Ravegnani; Armando Cama; Maria Luisa Garrè; Valeria Capra
Journal:  Neuro Oncol       Date:  2011-04-12       Impact factor: 12.300

2.  The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

Authors:  Elena Binda; Alberto Visioli; Fabrizio Giani; Giuseppe Lamorte; Massimiliano Copetti; Ken L Pitter; Jason T Huse; Laura Cajola; Nadia Zanetti; Francesco DiMeco; Lidia De Filippis; Annunziato Mangiola; Giulio Maira; Carmelo Anile; Pasquale De Bonis; Brent A Reynolds; Elena B Pasquale; Angelo L Vescovi
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

3.  Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM.

Authors:  Stephen J Florczyk; Kui Wang; Soumen Jana; David L Wood; Samara K Sytsma; Jonathan Sham; Forrest M Kievit; Miqin Zhang
Journal:  Biomaterials       Date:  2013-09-26       Impact factor: 12.479

Review 4.  Brain cancer stem cells.

Authors:  Sara G M Piccirillo; Elena Binda; Roberta Fiocco; Angelo L Vescovi; Khalid Shah
Journal:  J Mol Med (Berl)       Date:  2009-09-29       Impact factor: 4.599

Review 5.  Cancer stem cells: cell culture, markers, and targets for new therapies.

Authors:  Candace A Gilbert; Alonzo H Ross
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

6.  Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

Authors:  Amy M McCord; Muhammad Jamal; Uma T Shankavaram; Uma T Shankavarum; Frederick F Lang; Kevin Camphausen; Philip J Tofilon
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

7.  ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma.

Authors:  Yao Jin; Zhang Quan Bin; Huang Qiang; Chu Liang; Chen Hua; Dong Jun; Wang Ai Dong; Lan Qing
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-02       Impact factor: 4.553

8.  The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.

Authors:  Angel A Alvarez; Melvin Field; Sergey Bushnev; Matthew S Longo; Kiminobu Sugaya
Journal:  J Mol Neurosci       Date:  2014-05-30       Impact factor: 3.444

9.  Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen.

Authors:  Jiyong Kwak; Hye-Jin Shin; Se-Hoon Kim; Jin-Kyoung Shim; Ji-Hyun Lee; Yong-Min Huh; Eui-Hyun Kim; Eun-Kyung Park; Jong Hee Chang; Sun Ho Kim; Yong-Kil Hong; Dong-Seok Kim; Su-Jae Lee; Seok-Gu Kang
Journal:  Childs Nerv Syst       Date:  2013-06-28       Impact factor: 1.475

10.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.